Abstract PR010: Elucidating epigenetic regulators of GD2 in Ewing sarcoma
Ewing sarcoma (EWS) is the second most common solid bone and soft tissue malignancies in children and young adults. Patients receive multimodal therapy including chemotherapy and surgery, however prognosis remains poor in relapsed and metastatic disease. There are no FDA-approved immunotherapies for EWS. The disi...